Arkolith/Insider Trading/TNGX/Form 4

TRV GP IV, LLC

10% OwnerTango Therapeutics, Inc. (TNGX) · full profile →Form 4 · filed Oct 27, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.8M
Net Open-Market Flow
-$4.8M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 23, 2025Sell(S)477K$10.15$4.8M13.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-251606) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML